CLINICAL_TRIALS
trial_result
· 2019-10-21
Clinical Trial Update: MEG Study of Acute STX209 Effects in ASD [EARLY_Phase 1]
Summary
Early phase 1 trial update of MEG study assessing acute effects of STX209 in autism.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Timothy Roberts | Conditions: Autism Disorder | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2019-10-21